FA |
Fanconi Anemia |
IBMF |
Inherited Bone Marrow Failure |
ICL |
Inter-strand DNA Cross-Links |
rhIL-3 |
Interleukin 3 |
rhGM-CSF |
Granulocyte-Macrophage Colony-Stimulating
Factor |
rhG-CSF |
Granulocyte Colony-Stimulating Factor |
HSCT |
Hematopoietic Stem Cell Transplantation |
GT |
Gene Therapy |
Allo-HSCT |
Allogeneic Hematopoietic Stem Cell
Transplantation |
GvHD |
Graft versus Host Disease |
MSD |
Matched Sibling Donor |
OS |
Overall Survival |
MUD |
Mismatched Unrelated Donor |
CMV |
Cytomegalovirus |
AD |
Alternative Donor |
Haplo-HSCT |
Haploidentical Hematopoietic Stem Cell
Transplantation |
TCD |
T-Cell Depleted |
ATG |
Anti-Thymocyte Globulin |
CY |
Cyclophosphamide |
SAA |
Severe Aplastic Anemia |
TAI |
Thoraco-Abdominal Irradiation |
FLU |
Fludarabine |
QoF |
Quality of Life |
OM |
Oral Mucositis |
HNSCC |
Head and Neck Squamous Cell Carcinomas |
HC |
Hemorrhagic Cystitis |
PRES |
Posterior Reversible Encephalopathy Syndrome |
CsA |
Cyclosporine A |
TTP |
Thrombotic Thrombocytopenic Purpura |
AML |
Acute Myeloid Leukemia |
ST |
Solid Tumor |
TRM |
Transplantation Related Mortality |
PID |
Primary Immunodeficiency Disorder |
SCID |
Severe Combined Immunodeficiency |
HSPC |
Hematopoietic Stem Cell/Progenitor Cells |
iPSC |
Induced Pluripotent Stem Cells |